Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

A Look At AGNC Investment’s (AGNC) Valuation After Mixed Recent Share Price Performance

Event overview and recent share performance AGNC Investment (AGNC) has drawn fresh attention after recent share price moves, with the stock showing a 10.46% gain over the past month but a 7.63% decline across the past 3 months. See our latest analysis for AGNC Investment. At a share price of US$10.77, AGNC’s recent 10.46% 1 month share price return contrasts with a 7.63% 3 month share price decline, while the 1 year total shareholder return of 52.49% points to stronger results for long term...
ASX:NXT
ASX:NXTIT

A Look At NEXTDC (ASX:NXT) Valuation After Record Utilisation And A$2.2b Capital Plan Announcement

NEXTDC (ASX:NXT) has put fresh capital raising and growth plans in the spotlight, outlining record contracted utilisation alongside a A$2.2b capital plan and a A$1.51b follow on equity offering. See our latest analysis for NEXTDC. The fresh capital plan and equity raise come after a period of firm momentum, with the 7 day share price return of 7.79% and 1 month share price return of 9.80% feeding into a 1 year total shareholder return of 34.73%. If you are assessing how other AI...
NasdaqGS:HALO
NasdaqGS:HALOBiotechs

Assessing Halozyme Therapeutics (HALO) Valuation After Recent Share Price Strength Without Major News

Halozyme Therapeutics: Event Overview and Recent Share Performance Halozyme Therapeutics (HALO) has recently drawn investor attention without a single headline event driving sentiment. This shifts focus squarely onto its share performance and fundamentals for context. The stock closed at US$69.57, with a 0.4% move over the past day, about 3.9% over the past week, and roughly 9.7% over the past month, while the past 3 months show a 1.2% decline. See our latest analysis for Halozyme...
NYSE:MPLX
NYSE:MPLXOil and Gas

A Look At MPLX (MPLX) Valuation As Long Term Returns Contrast Recent Flat Performance

MPLX (MPLX) is back on investor screens after recent trading left the units around $55.69, with the stock showing mixed returns over the past month and past 3 months. See our latest analysis for MPLX. While the share price has eased recently, with a 1 month share price return decline of 3.97% and a relatively flat 3 month move of 0.27%, the longer term picture is stronger, reflected in a 1 year total shareholder return of 22.41% and a 5 year total shareholder return of 226.63%. If MPLX has...
NYSE:DCOM
NYSE:DCOMBanks

How Hiring Meyer Eichler’s Team And Launching New Finance Unit At Dime (DCOM) Has Changed Its Investment Story

Dime Community Bancshares recently expanded its leadership bench by hiring Meyer Eichler and several veteran teams from Flagstar, Signature Bank, and other regional banks, adding around 22 bankers and launching a new Equipment and Franchise Finance vertical. This influx of experienced relationship bankers and product specialists could meaningfully reshape how Dime builds its commercial franchise and deepens client relationships across New York and the Lakewood, NJ market. Next, we will...
KOSE:A005930
KOSE:A005930Tech

Is Samsung Electronics (KOSE:A005930) Still Attractive After Its 294% One Year Surge?

If you have been wondering whether Samsung Electronics at ₩214,500 is still reasonably priced after its strong run, this breakdown will help you frame that question clearly. The stock has logged returns of 6.7% over the last 7 days, 7.6% over 30 days, 66.9% year to date and 294.0% over 1 year. These figures put recent share price moves firmly in focus when thinking about value and risk. Recent coverage has focused on Samsung Electronics as a key name in global technology, with attention on...
NYSE:EBF
NYSE:EBFCommercial Services

Ennis (EBF) Q3 EPS Slowdown Tests Bullish Earnings Growth Narratives

Ennis (EBF) has just wrapped up its latest quarter with Q3 FY 2026 revenue of US$100.2 million, basic EPS of US$0.43 and net income of US$10.8 million, setting the tone for how the rest of the fiscal year is shaping up. The company has seen quarterly revenue move from US$92.7 million in Q4 FY 2025 to US$100.2 million in Q3 FY 2026. Over the same stretch, basic EPS ranged from US$0.35 to US$0.51, giving investors a clear view of how the top and bottom lines are tracking into FY 2026 and what...
NYSE:MSCI
NYSE:MSCICapital Markets

Is It Time To Reassess MSCI (MSCI) After Recent 7.7% Share Price Gain?

If you are wondering whether MSCI's current share price lines up with its underlying worth, this breakdown will help you assess what you are really paying for. The stock last closed at US$566.95, with reported returns of 2.6% over the past week and month, 0.3% year to date, and 7.7% over the past year. These figures may influence how you think about both growth potential and risk. Recent coverage has focused on MSCI's role as a major index and analytics provider, as investors pay close...
NasdaqGS:VEON
NasdaqGS:VEONWireless Telecom

What VEON (VEON)'s US$5.16 Billion ESOP Shelf Registration Means For Shareholders

Earlier this month, VEON Ltd. filed a shelf registration for up to US$5.16 billion in common shares, covering 94,411,725 shares in connection with an ESOP-related offering. This sizable shelf capacity gives VEON flexibility to issue a large volume of equity over time, which may influence how investors assess potential dilution, capital raising plans, and employee alignment with the company’s long-term direction. Next, we will examine how this large ESOP-related shelf registration could...
NYSE:ZBH
NYSE:ZBHMedical Equipment

Zimmer Biomet Robotics Milestone And New Tech Leadership Spark Valuation Questions

Zimmer Biomet Holdings (NYSE:ZBH) supported the nation’s first complete robotic assisted shoulder replacement in an ambulatory surgery center. The company appointed Dr. Jonathan M. Vigdorchik as Chief Science, Technology, and Medical Affairs Officer to oversee AI, robotics, and smart implant efforts. Zimmer Biomet enters this news cycle with shares at $95.48 and mixed long term returns. The stock is up 8.7% over the past 30 days and 6.1% year to date, while the 3 year and 5 year returns...
NYSE:AORT
NYSE:AORTMedical Equipment

Will FDA Approval Of NEXUS And Endospan Option Reshape Artivion's (AORT) Minimally Invasive Aortic Strategy

Artivion, Inc. recently announced that the FDA has approved the PMA for Endospan’s NEXUS Aortic Arch System, triggering a 90‑day window in which Artivion can exercise its option to acquire Endospan, supported by a US$150 million delayed draw term loan arranged in advance. NEXUS, backed by TRIOMPHE trial data showing strong one‑year outcomes in high‑risk aortic arch patients, could broaden Artivion’s presence in minimally invasive aortic repair where alternatives to open‑chest surgery have...
NYSE:VOYA
NYSE:VOYADiversified Financial

Is Voya’s Completed US$9.87 Billion Buyback Altering The Investment Case For Voya Financial (VOYA)?

Between January 1 and March 31, 2026, Voya Financial repurchased 2,068,788 shares for US$150,000,000, completing a buyback program totaling about 205.12 million shares and US$9.87 billion originally announced on March 18, 2014. This completion marks the end of a long-running capital return initiative, highlighting how materially Voya has reduced its share count over time. We’ll now examine how the completion of this long-running share repurchase program may influence Voya Financial’s broader...
NYSE:NCLH
NYSE:NCLHHospitality

Norwegian Cruise Line Revisits Philadelphia With Homeport And Valuation Questions

Norwegian Cruise Line Holdings (NYSE:NCLH) is returning to Philadelphia with new homeport sailings for the first time in 15 years. The company plans to introduce year round itineraries from the city, supported by investment in a new cruise terminal. This move expands Norwegian’s presence in the Mid Atlantic region and opens access to additional source markets along the US East Coast. Norwegian Cruise Line Holdings operates global cruise brands that compete for vacation spending against...
NYSE:MOS
NYSE:MOSChemicals

Did Geopolitical Blockade Fears Just Reshape Mosaic's (MOS) Fertilizer Supply Risk Narrative?

The Mosaic Company recently faced heightened investor attention ahead of its Q1 2026 earnings release, as analysts projected a sharp year-on-year EPS decline while fertilizer producers reacted to geopolitical headlines. An especially important angle is how concerns over a potential U.S. blockade disrupting global fertilizer supply have shifted sentiment across Mosaic's industry. Now, we will examine how these supply disruption concerns may influence Mosaic's longer-term investment narrative...
TSE:4480
TSE:4480Healthcare Services

3 Asian Stocks That May Be Trading Below Their Estimated Intrinsic Values

Amidst a backdrop of geopolitical developments and economic data releases, Asian markets have shown resilience, with indices in Japan and China experiencing gains driven by optimism around diplomatic progress and robust economic figures. In this environment, identifying stocks that may be trading below their estimated intrinsic values can present opportunities for investors looking to capitalize on potential market inefficiencies.
TPEX:3680
TPEX:3680Semiconductor

Asian Growth Stocks With Significant Insider Ownership

As global markets experience shifts influenced by geopolitical developments and economic data, Asia's equity landscape remains a focal point for investors seeking growth opportunities. In this environment, companies with high insider ownership can offer unique insights into potential growth trajectories, as insiders often have a vested interest in the company's long-term success.
SEHK:533
SEHK:533Specialty Retail

April 2026's Asian Penny Stocks To Watch

As of April 2026, Asian markets are navigating a complex landscape shaped by geopolitical developments and mixed economic signals. Amidst this backdrop, the allure of penny stocks remains significant for investors seeking opportunities in smaller or newer companies that may offer value and growth potential. While the term "penny stocks" might seem outdated, these investments can still be relevant when backed by solid financials, offering a unique combination of affordability and potential...
SZSE:002885
SZSE:002885Electronic

Discovering Asia's Undiscovered Gems in April 2026

As global markets experience a positive shift, buoyed by de-escalating Middle East tensions and strong earnings reports, the Asian markets present intriguing opportunities for investors seeking growth beyond the well-trodden paths. In this dynamic environment, identifying promising small-cap stocks involves looking for companies with robust fundamentals that can capitalize on regional economic trends and navigate geopolitical developments effectively.